<DOC>
	<DOCNO>NCT00001449</DOCNO>
	<brief_summary>The purpose study determine clinical toxicity associate administer sequential dFdC one hour infusion follow continuous infusion FUdR 24 hour low dose oral LV weekly three week four .</brief_summary>
	<brief_title>A Phase I Study Weekly Gemcitabine Combination With Infusional Fluorodeoxyuridine Oral Calcium Leucovorin Adult Cancer Patients</brief_title>
	<detailed_description>The MTD biochemically active dose FUDR 24-hour gemcitabine 2-hour infusion determine first ( Part A ) ; biochemically active FUDR dose less MTD , new patient enter determine maximum tolerated duration FUDR infusion ( Part B ) .</detailed_description>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Floxuridine</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnostically prove locally advanced , unresectable primary recurrent solid tumor lymphoma metastatic solid tumor fail standard therapy therapy available . Objectively measurable disease require . No patient leukemia primary metastatic CNS malignancy . PRIOR/CONCURRENT THERAPY : Biologic Therapy : Greater 4 week since prior immunotherapy recover toxic effect . Chemotherapy : Greater 4 week since prior chemotherapy recover toxic effect follow exception : At least 6 week since prior mitomycin C nitrosourea therapy . At least 3 month since prior suramin therapy . Endocrine Therapy : Not specify Radiotherapy : At least 2 week since prior radiotherapy ( 4 week least 21 % marrow irradiate ) recover toxic effect . Surgery : Recovered prior surgery . PATIENT CHARACTERISTICS : Age : 18 . Performance status : ECOG 02 Hematopoietic : AGC least 2,000/microL . Platelet count least 100,000/microL . Hepatic : Bilirubin great 2.0 mg/dL . Renal : Creatinine great 2.0 mg/dL . OTHER : No failure prior gemcitabine therapy . No concurrent cimetidine ( ranitidine antiulcer agent allow ) . No active infection require intravenous antibiotic therapy . HIV negative . No medical contraindication protocol therapy . No pregnant nursing woman . Adequate contraception require fertile patient .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 1999</verification_date>
	<keyword>Anti-Cancer Agents</keyword>
	<keyword>Antimetabolite</keyword>
	<keyword>Palliation</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>